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Abstract
Sexual activity is a multifaceted activity, involving complex interactions between the nervous system, the
endocrine system, the vascular system and a variety of structures that are instrumental in sexual
excitement, intercourse and satisfaction. Sexual function has three components i.e., desire, arousal and
orgasm. Many sexual dysfunctions can be categorized according to the phase of sexual response that is
affected. In actual clinical practice however, sexual desire, arousal and orgasmic difficulties more often
than not coexist, suggesting an integration of phases. Sexual dysfunction can result from a wide variety
of psychological and physiological causes including derangements in the levels of sex hormones and
neurotrensmitters. This review deals with the biology of different phases of sexual function as well as
implications of hormones and neurotransmitters in sexual dysfunction

Keywords
biology, dysfunction, sexual

Disciplines
Medicine and Health Sciences

This journal article is available at Research Online: https://ro.uow.edu.au/medpapers/20

Peer Reviewed, Open Access, Free
Published Quarterly
Mangalore, South India
ISSN 0972-5997
Volume 8, Issue 1; Jan-Mar 2009

Review

Biology of Sexual Dysfunction
Authors
Anil Kumar Mysore Nagaraj,
DNB, Lecturer, Dept of Psychiatry, K S Hegde Medical Academy, Mangalore, India,
Nagesh Brahmavar Pai,
Clinical Associate Professor, Graduate School of Medicine, University of Wollongong, Australia,
Satheesh Rao,
Professor and Head, Dept of Psychiatry, K S Hegde Medical Academy, Mangalore, India,
Telkar Srinivasarao Sathyanarayana Rao,
Professor and Head, Dept of Psychiatry, J S S Medical College, Mysore, India,
Nishant Goyal,
Senior Resident, Central Institute of Psychiatry, Ranchi, India
Address For Correspondence
Anil Kumar Mysore Nagaraj,
Lecturer, Dept of Psychiatry,
K S Hegde Medical Academy,
Mangalore, India
E-mail: nagarajakm24@gmail.com
Citation
Anil Kumar MN, Pai NB, Rao S, Rao TSS, Goyal N. Biology of Sexual Dysfunction. Online J Health Allied Scs.
2009;8(1):2
URL
http://www.ojhas.org/issue29/2009-1-2.htm
Submitted: Oct 13, 2008; Suggested review Jan 12, 2009; Resubmitted: Jan 22, 2009 Accepted: Apr 9, 2009; Published: May 5, 2009

Abstract:

Sexual activity is a multifaceted activity, involving complex interactions between the nervous system, the endocrine system,
the vascular system and a variety of structures that are instrumental in sexual excitement, intercourse and satisfaction.
Sexual function has three components i.e., desire, arousal and orgasm. Many sexual dysfunctions can be categorized
according to the phase of sexual response that is affected. In actual clinical practice however, sexual desire, arousal and
orgasmic difficulties more often than not coexist, suggesting an integration of phases. Sexual dysfunction can result from a
wide variety of psychological and physiological causes including derangements in the levels of sex hormones and
neurotrensmitters. This review deals with the biology of different phases of sexual function as well as implications of
hormones and neurotransmitters in sexual dysfunction
Key Words: Sexual dysfunction, Hormones, Neurotransmitters
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Introduction:
Sexual activity is a multifaceted activity, involving
complex interactions between the nervous system the
endocrine system, the vascular system and a variety of
structures that are instrumental in sexual excitement,
intercourse and satisfaction.(1) Sexual function is our
physiological capacity to experience desire, arousal and
orgasm. Normal sexual function requires the integrity of
the genitalia, the reliable co-ordination of blood flow,
the activation of various smooth and skeletal muscles
and the stimulation of local secretions. This is linked with
cognitive processes attending to the sexual meaning of
what is happening. Problem anywhere in the entire
sequence may lead to sexual dysfunction. Sexual
dysfunction can result from a wide variety of
psychological and physical causes. Pathophysiology of
sexual dysfunction involves derangements in the levels of
sex hormones and neurotransmitters.

Sexual Response Cycle:
As defined by Kaplan, this consists of three phases- desire, arousal (excitement) and orgasm.(2) However, the
division is arbitrary and it only helps to organize clinical
and research oriented problems involving sexuality. In
clinical practice sexual desire, arousal and orgasmic difficulties more often than not coexist, suggesting an integration of phases.
1. Desire (Libido)
It is a complex construct involving physiologic, cognitive,
behavioural, developmental and cultural components,(3)
which are thought of as the broad interest in sexual
experiences including thoughts, fantasies, dreams and
wishes along with an interest in initiating or engaging in
sexual activity and frustration due to lack of opportunity
for sexual expression.(1) This stage is hypothetically a
dopaminergic phenomenon mediated by mesolimbic
dopaminergic "reward centre" including medial preoptic
area (MPA) and anterior hypothalamus. The reward
centre receives inputs from serotonergic and
noradrenergic neurons and contains dopaminergic cell
bodies.(4)
Other
contributing
factors
include
testosterone and oxytocin, as well as personality
characteristics and psychosocial context.
2. Arousal
Sexual arousal is characterized by a subjective sense of
sexual
excitement
associated
with
observable
physiological changes such as penile tumescence in men
and pelvic vasocongestion, vaginal lubrication and
swelling of external genitalia in women. These responses
may be accompanied in both sexes by other bodily
changes like skin flushing, tachycardia etc.(5)
Psychogenic penile erections are mediated by impulses
descending from the cerebral cortex and limbic system
to reach thoracolumbar sympathetic ganglia (inferior
hypogastric plexus) and sacral parasympathetic ganglion.
(6) Baseline non-erect state is maintained by tonic

adrenergic stimulation of µ and µ adrenoceptors.(7)
1
2
The sacral plexus via the pudendal and perineal nerves,
initiates tactile reflexogenic erections. Hypogastric plexus
mediates psychogenic penile erections. Efferent impulses
from the parasympathetic vasodilator fibers in sacral
plexus initiate vasodilatory mechanism for penile
erection.(8)
Psychological sexual arousal in women begins with
increased
clitoral
length
and
diameter,
and
vasocongestion of the vagina, vulva, clitoris, uterus, and
possibly the urethra. Pelvic nerve stimulation results in
clitoral smooth muscle relaxation and arterial smooth
muscle dilation. With sexual arousal, there is an increase
in clitoral cavernosal artery inflow and an increase in
clitoral intracavernous pressure that leads to tumescence
and extrusion of the clitoris. Engorgement of the genital
vascular network increases pressure inside the vaginal
capillaries and results in lubrication of the epithelial
surface of the vaginal wall. The neurotransmitters that
mediate clitoral and arterial smooth muscle dilation
remain undetermined.(9)
3. Orgasm
Orgasm in both sexes is characterized by climax of sexual
pleasure associated with rhythmic contractions of
perineal muscles, cardiovascular and respiratory changes
and a release of sexual tension.(3)
In men, there are two physiological stages of orgasm – (i)
Emission, (ii) Ejaculation
Emission involves the propulsion of seminal fluid to the
bulbar urethra by the contraction of the smooth muscles
of the vas deferens, prostate and seminal vesicles. This
process is thought to be under the control of
thoracolumbar sympathetic nerves which release
norepinephrine on to alpha receptors. After emission,
the external sphincter is opened to allow release of fluid.
In the second stage, a local, parasympathetic, sacral
spinal reflex activates the striated muscles surrounding
the bulbar urethra, producing ejaculation. The rhythmic
contraction of these muscles propels the semen outward.
It is unclear to what degree the occurrence and intensity
of orgasm are shaped by central neurochemical and
cognitive processes.(5) Smooth muscle controlled
emission and striated muscle determined ejaculation
involve
separate
nerve inputs
and
can be
pharmacologically distinguished.
In women less is known about the neural mechanisms of
orgasm and the process is assumed to be largely similar
to that in the male. Women are capable of experiencing
multiple orgasms in rapid succession, without the more
prolonged refractory periods. Mechanisms that make this
possible are not clear, although it is hypothesized that
women are less sensitive to the post-orgasmic secretion
of prolactin that is hypothesized to produce a refractory
period in men and women.(10)
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Some women ejaculate fluid from the urethra with
orgasm. Chemical analysis of this fluid confirms that
while it may be mixed with small amounts of urine, it is
predominantly a secretion from the paraurethral glands,
thought to be a vestigial equivalent of the prostate. But
this goes unrecognized when it occurs in a retrograde
direction.(11)

Role of pituitary, adrenal and sex hormones in
Sexual function:

Testosterone, estrogen, progesterone, prolactin oxytocin,
cortisol, pheromones are the various hormones implicated in sexual function.
Testosterone
Testosterone has been shown to restore nocturnal penile
tumescence responses in hypogonadal men, in whom
this is impaired.(12) A recent study showed testosterone
increased sexual arousal and enjoyment among
hypogonadal and normal men, and had a positive effect
on mood only among men with abnormally low
testosterone levels.(13) In normal adult males, there
exists wide individual variability in circulating
testosterone levels that do not seem to be linked in any
meaningful, way with individual differences in levels of
drive or sexual behavior.(14) It is believed that the level
of testosterone required for sexual interest and activity
in adult males is lower than normal males’ circulating
levels of testosterone. Among males with normal
testosterone levels, testosterone has not been shown to
facilitate erection.(15)
In an earlier study of women who had undergone
bilateral oophorectomy and adrenalectomy, removal of
the ovaries decreased sexual desire to a certain extent,
but removal of the adrenal glands had an even more
deleterious effect on desire.(16) Studies of surgically
menopausal women generally indicate that desire drops
from presurgery level and may be restored with
exogenous administration of supraphysiological levels of
testosterone with or without estradiol.(17)
Estrogens
Most research suggests that estrogens have little direct
influence on sexual desire in either males or females. In
men, relatively high levels of exogenous estrogen have
been somewhat effective in inhibiting sexual desire
among sex offenders and men who experience
uncontrollable sexual urges.(18,19) In women, some
early studies have claimed that estrogen (especially
estradiol) is important for normal sexual desire, but most
current researches agree that estrogens play only a
minimal role in female sexual desire.(20,21)
Estrogen deficiency, as occurs with menopause, causes a
decrease in genital vasocongestion, lubrication and
atrophy of the vaginal epithelium. Such changes not only
impair the physiological sexual arousal response in
women and may cause dyspareunia (painful intercourse),
but can adversely influence the psychological experience

of sexual arousal. These changes could be expected to
indirectly impair sexual desire.(22)
Progesterone
Early studies have revealed a decrease in sexual desire in
men receiving intramuscular injections of progesterone.
(23,24) No controlled studies have been conducted on
the relationship between progesterone treatment and
sexual desire in men.
Certain oral contraceptives that increase progesterone
levels throughout the menstrual cycle in female have
been associated with decreased sexual interest and
desire.(25,26) It is generally agreed on, however, that
progesterone treatment does not have a substantial
influence on the sexual desire of either premenopausal
or postmenopausal women.(17,27,28)
Prolactin
Men and women with abnormally high levels of prolactin
report a decrease in sexual interest that is restored with
bromocriptine treatment.(29) It is unclear whether the
reversal of sexual symptoms secondary to bromocriptine
treatment is attributable to the lowering of serum
prolactin levels, to the correction of hypothalamic
dopaminergic dysregulation, or to an interaction
between these two mechanisms.(30)
Prolactin's effect on other aspects of human sexual
behaviour remains equivocal. Erectile dysfunction has
been described in men with abnormally high levels of
prolactin, (31) but has also been described in men with
unusually low levels of prolactin, (32) suggesting more
than a simple inhibitory role of prolactin on erectile
ability. In women, abnormally high levels of prolactin
have been associated with amenorrhoea, infertility and
decreased sexual ability.(33)
Oxytocin
Circulating levels of oxytocin increase during sexual
arousal and orgasm in both men and women.(34) Using a
continuous
blood
sampling
technique
and
electromyography, it was reported to have a positive
correlation between oxytocin levels and the intensity, but
not the duration of orgasmic contraction in males and
females.(35) Most of what we know about the influence
of oxytocin on sexual behaviour however is based on
animal studies.
Cortisol
Hypercortisolism (Cushing syndrome) can produce a
constellation of symptoms including depression,
insomnia and decreased libido in males and
females. Cortisol levels were higher in men with
psychogenic erectile dysfunction who demonstrated a
poor response to intracavernosal injection of a smooth
muscle relaxant.(36)
Pheromones
Pheromones are substances secreted from glands at the
anus, urinary outlet, breasts and mouth. In a recent
double blind, placebo-controlled study, it was reported
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that women exposed to a synthesized human male
pheromone reported higher levels of sexual intercourse,
sleeping with a romantic partner, but no change in
masturbation frequency. The authors interpreted these
findings as evidence for male pheromones increasing the
sexual attractiveness of men to women.(37)

Role of neurotransmitters in sexual function
Nitric oxide, serotonin, dopamine, epinephrine,
norepinephrine, acetylcholine, histamine, GABA are all
implicated to have roles in sexual function.
Neurotransmitters act both within the brain and in
peripheral organs, and therefore may play complex and
interacting roles in promoting and facilitating sexual
functioning.
(a) Nitric oxide (endothelial relaxing factor)
Nitric oxide (NO) is an essential component in the
production
of
penile,
and
possibly,
clitoral
vasocongestion and tumescence. The release of NO by
cholinergic and non-cholinergic nerves appears to be the
major contribution of the parasympathetic nervous
system.(38) As described above, NO is now understood
to be the most significant mediator of vascular smooth
muscle relaxation, responsible for engorgement of
erectile tissue in men and women.
Sexual stimulation leads to NO production that in turn
stimulates the release of guanylate cyclase. Guanylate
cyclase converts guanosine triphosphate to cGMP and
cGMP produces relaxation of the smooth muscles of the
penile arteries and corpus cavernosum resulting in
increased blood flow into the penis.(39) Some evidence
suggests that this may also occur in the clitoris.(40)
Normally, cGMP is metabolized by cyclic nucleotide
phosphodiestrase isozymes into gunanosine 5'monophosphate. As long as sexual stimulation continues,
cGMP production and metabolism remain balanced and
penile or clitoral tumescence is sustained.(41) Erectile
dysfunction can result when this process is not working
normally or when it is partially or completely disrupted.
(5)
(b) Vasoactive Intestinal Polypeptide (VIP)
VIP has been less well understood but is shown to colocalize with NO is nerves to genital blood vessels and
smooth muscle. In women, systemic administration and
local subepithelial injection of VIP result in increased
vaginal blood flow and lubrication.(9) In addition, sexual
arousal raises the level of VIP found in the plasma. In
men VIP also co-localizes with NO and has been shown
to play an important role in erection.(5)
(c) Serotonin
Serotonin acts at both central and peripheral receptors
in the mediation of sexual function. (5)
Centrally, serotonin appears to downregulate and
diminish levels of mesolimbic dopaminergic activity and
to elevate prolactin, resulting in decreased libido.(42,43)

In addition, serotonergic activation of different receptor
subtypes has differential effects on sexual functioning.
Activation of receptor subtype IA lowers the thershold
for ejaculations, while activation of 2A, 1B or IC inhibits

sexual behaviours and stimulation of 2C facilitates
behaviour in animal models.(44)

Peripherally, at spinal or end-organ receptors, serotonin
has inhibitory effects on ejaculation in animals.(45) Also
serotonin tends to cause problems with orgasm and
desire more than arousal itself. Serotonin even acts on
the smooth muscles of the genitals possibly inhibiting the
muscular contractions that characterize orgasm.(5)
Further, serotonin acts at peripheral nerves, where it
appears to affect the flow of genital sensory information.
Lastly, serotonin may delay orgasm through pre-synaptic
inhibition of adrenergic transmission.(45)
(d) Dopamine
All the four major dopaminergic CNS pathways are
proposed to play a role in sexual behavior. The
incertohypothalamic pathway stimulation increases all
phases of male rat sexual behaviour and induces penile
erection. In female rats it induces sexually receptive
posture called lardosis. The mesolimbic pathway is
involved in the anticipatory phase of sexual activity
associated with motivation and sexual reward. The
nigrostriatal pathway is important in the motor
behaviour required for consummatory sexual activity in
male rats. Lastly the tubero infudibular pathway appears
to play a role in baseline sexual interest as opposed to
more acute behavioural changes.(5,46,47)
Regarding relationship between dopamine and prolactin,
it remains unclear whether hyperprolactinemia itself is
causative or acts as a surrogate marker for decreased
dopmine. A recent F-MRI study demonstrated an
increase in blood flow to specific dopaminergic and
other brain structures when 17 college men and women
viewed pictures of people they love and are sexually
attracted to.(48)
(e) Epinephrine
Plasma levels of epinephrine have been shown to
increase prior to viewing an erotic film, slowly increase
during masturbation, peak at orgasm, and return to
baseline level within several minutes of orgasm.(49) The
epinephrine
and
norepinephrine
metabolite,
vanillylmandelic acid, increases prior to intercourse and
continue to be elevated over baseline upto 23 hours
following sexual activity.(50)
(f) Norepinephrine
In men, blood plasma NE levels were positively
correlated with arousal and erection during masturbation
and sexual activity, increased upto 12-fold at orgasm and
declined to baseline levels within 2 minutes of reaching
orgasm.(51,52) Studies suggest that NE is also active
during the sexual response cycle of women. Blood
plasma levels of NE increased during masturbation,
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peaked at orgasm, and slowly declined following orgasm
in normally functioning women.(49,52)

•

(g) Acetylcholine
Erection occurs when the smooth muscles of the corpus
cavernosum relax permitting increased blood flow into
the penile tissue. The human corpus cavernosum is
innervated by cholinergic nerves and contains cholinergic
receptors suggesting endogenous cholinergic activity in
the penile tissue.(53,54)
Acetylcholine (Ach) appears to play a less direct role in
sexual functioning that is largely a function of
maintaining the balance of cholinergic and sympathetic
input at the genital level.(5) Ach antagonist, atropine
showed no effect on either vaginal vasocongestion or
orgasm in women and large doses were insufficient to
block penile erection in men,(9) though in vitro
administration of Ach to pre-contracted corpus
cavernosum induced smooth muscle relaxation.(7) Thus
Ach is sufficient to produce vasocongestion, but not
essential for this effect.

(h) Histamine
Very little is known about the role of histamine in
facilitating sexual functioning, but evidence suggests that
activity at both H2 and H3 receptors in the penis can

cause erection.(56) There are a few case reports of
decreased desire in both men and women taking
cimetidine (H2 antagonist), the mechanism of which may
be, decreased peripheral response to testosterone (7) or
decreased metabolism of estradiol leading to
gynaecomastia in men.(57)

(i) Gama aminobutyric acid (GABA)
GABA enhancing benzodiazepine use has been
implicated in case reports of decreased libido, erectile
dysfunction and anorgasmia.(58) While mechanisms are
poorly understood, it is hypothesised that centrally
mediated sedation and peripheral muscle relaxation may
be responsible.(5)
Apart from the above mentioned ones, many other
putative
neurotransmitters,
including
argininevasopressin, angiotensin II, substance P, neuropeptide-Y,
a-MSH, Gn RH are involved in sexual functioning, but
there is little research into their precise role.(59)

There are three proposed roles for cholinergic
stimulation in promoting sexual arousal specifically

•
•

Synthesis and secretion of NO and VIP, that are
essential for arousal.(5)

Alteration of the balance of sympathetic and
parasympathetic inputs.(7)
Facilitation of lubrication by increasing secretions.
(55)

Table 1: Stages of sexual response:(60)
Stages of sexual response
Desire

The spontaneous occurrence of sexual thoughts, fantasies, dreams and wishes, along with an
interest in initiating or engaging in sexual activity

Arousal:
Peripheral or physical;
Central or subjective

Genital (vascular engorgement and lubrication) and systemic responses (tachycardia,
hyperventilation; etc.) to sexual stimulation.
Psychological sense of excitement

Orgasm

Intense peak of sexual pleasure accompanied by rhythmic contractions of the genital and
reproductive organs

Resolution

Return to baseline, unaroused state, characterised by loss of vasocongestion in the penis and vulva

Table 2: Summary of Role of Hormones: (60)
Stage of sexual response

Facilitate sexual function

Inhibits sexual function

Desire

Testosterone, Oxytocin

Prolactin, Cortisol

Arousal

Testosterone, Estrogen, Oxytocin

-

Orgasm

Oxytocin

-

Conclusion:
Sexual function is a complex phenomenon
involving an orchestra of chemical elements
ranging from small molecules like nitric oxide to
peptides like oxytocin. We are aware that
derangements
of
various
hormones
and
neurotransmitters are
involved in sexual
dysfunction but their precise role is not known.

Further, putative neurotransmitters are gaining
more implications in sexual dysfunction. Deeper
investigation into these areas will no doubt reveal
greater insight about sexual functioning which in
turn assists in efficient management of sexual
dysfunction
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